vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Smith Douglas Homes Corp. (SDHC). Click either name above to swap in a different company.
Smith Douglas Homes Corp. is the larger business by last-quarter revenue ($260.4M vs $164.7M, roughly 1.6× PTC THERAPEUTICS, INC.). Smith Douglas Homes Corp. runs the higher net margin — 1.4% vs -82.0%, a 83.3% gap on every dollar of revenue. On growth, Smith Douglas Homes Corp. posted the faster year-over-year revenue change (-9.4% vs -22.7%). Smith Douglas Homes Corp. produced more free cash flow last quarter ($8.7M vs $-36.6M). Over the past eight quarters, Smith Douglas Homes Corp.'s revenue compounded faster (17.3% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
PTCT vs SDHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $260.4M |
| Net Profit | $-135.0M | $3.5M |
| Gross Margin | — | 19.9% |
| Operating Margin | -43.3% | 6.5% |
| Net Margin | -82.0% | 1.4% |
| Revenue YoY | -22.7% | -9.4% |
| Net Profit YoY | -104.8% | -14.3% |
| EPS (diluted) | $-1.63 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | $260.4M | ||
| Q3 25 | $211.0M | $262.0M | ||
| Q2 25 | $178.9M | $223.9M | ||
| Q1 25 | $1.2B | $224.7M | ||
| Q4 24 | $213.2M | $287.5M | ||
| Q3 24 | $196.8M | $277.8M | ||
| Q2 24 | $186.7M | $220.9M | ||
| Q1 24 | $210.1M | $189.2M |
| Q4 25 | $-135.0M | $3.5M | ||
| Q3 25 | $15.9M | $2.1M | ||
| Q2 25 | $-64.8M | $2.4M | ||
| Q1 25 | $866.6M | $2.7M | ||
| Q4 24 | $-65.9M | $4.1M | ||
| Q3 24 | $-106.7M | $5.3M | ||
| Q2 24 | $-99.2M | $3.6M | ||
| Q1 24 | $-91.6M | $3.0M |
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | 23.8% | ||
| Q4 24 | — | 25.5% | ||
| Q3 24 | — | 26.5% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | — | 26.1% |
| Q4 25 | -43.3% | 6.5% | ||
| Q3 25 | 1.4% | 6.6% | ||
| Q2 25 | -19.5% | 7.7% | ||
| Q1 25 | 82.5% | 8.7% | ||
| Q4 24 | -76.2% | 10.4% | ||
| Q3 24 | -27.7% | 14.2% | ||
| Q2 24 | -21.5% | 11.7% | ||
| Q1 24 | -21.6% | 11.3% |
| Q4 25 | -82.0% | 1.4% | ||
| Q3 25 | 7.5% | 0.8% | ||
| Q2 25 | -36.3% | 1.1% | ||
| Q1 25 | 73.7% | 1.2% | ||
| Q4 24 | -30.9% | 1.4% | ||
| Q3 24 | -54.2% | 1.9% | ||
| Q2 24 | -53.1% | 1.7% | ||
| Q1 24 | -43.6% | 1.6% |
| Q4 25 | $-1.63 | $0.39 | ||
| Q3 25 | $0.20 | $0.24 | ||
| Q2 25 | $-0.83 | $0.26 | ||
| Q1 25 | $10.04 | $0.30 | ||
| Q4 24 | $-0.85 | $0.50 | ||
| Q3 24 | $-1.39 | $0.58 | ||
| Q2 24 | $-1.29 | $0.40 | ||
| Q1 24 | $-1.20 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $12.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-205.3M | $86.7M |
| Total Assets | $2.9B | $557.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $12.7M | ||
| Q3 25 | $1.7B | $14.8M | ||
| Q2 25 | $2.0B | $16.8M | ||
| Q1 25 | $2.0B | $12.7M | ||
| Q4 24 | $1.1B | $22.4M | ||
| Q3 24 | $1.0B | $23.7M | ||
| Q2 24 | $1.1B | $17.3M | ||
| Q1 24 | $884.8M | $32.8M |
| Q4 25 | $-205.3M | $86.7M | ||
| Q3 25 | $-155.8M | $82.2M | ||
| Q2 25 | $-206.5M | $80.0M | ||
| Q1 25 | $-185.8M | $76.9M | ||
| Q4 24 | $-1.1B | $73.6M | ||
| Q3 24 | $-1.1B | $68.4M | ||
| Q2 24 | $-980.2M | $62.1M | ||
| Q1 24 | $-893.9M | $59.7M |
| Q4 25 | $2.9B | $557.6M | ||
| Q3 25 | $2.6B | $571.6M | ||
| Q2 25 | $2.6B | $570.2M | ||
| Q1 25 | $2.7B | $513.9M | ||
| Q4 24 | $1.7B | $475.9M | ||
| Q3 24 | $1.8B | $460.1M | ||
| Q2 24 | $1.9B | $429.3M | ||
| Q1 24 | $1.8B | $401.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $9.8M |
| Free Cash FlowOCF − Capex | $-36.6M | $8.7M |
| FCF MarginFCF / Revenue | -22.3% | 3.4% |
| Capex IntensityCapex / Revenue | 1.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 2.77× |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | $-36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | $9.8M | ||
| Q3 25 | $-66.3M | $22.8M | ||
| Q2 25 | $-58.3M | $-28.9M | ||
| Q1 25 | $870.1M | $-34.9M | ||
| Q4 24 | $-30.0M | $5.5M | ||
| Q3 24 | $-77.0M | $22.9M | ||
| Q2 24 | $-71.5M | $39.0K | ||
| Q1 24 | $70.8M | $-9.3M |
| Q4 25 | $-36.6M | $8.7M | ||
| Q3 25 | $-69.7M | $21.4M | ||
| Q2 25 | $-59.6M | $-31.1M | ||
| Q1 25 | $868.4M | $-35.9M | ||
| Q4 24 | $-33.8M | $4.8M | ||
| Q3 24 | $-77.5M | $22.3M | ||
| Q2 24 | $-78.8M | $-2.1M | ||
| Q1 24 | $61.2M | $-9.7M |
| Q4 25 | -22.3% | 3.4% | ||
| Q3 25 | -33.1% | 8.2% | ||
| Q2 25 | -33.3% | -13.9% | ||
| Q1 25 | 73.8% | -16.0% | ||
| Q4 24 | -15.8% | 1.7% | ||
| Q3 24 | -39.4% | 8.0% | ||
| Q2 24 | -42.2% | -1.0% | ||
| Q1 24 | 29.1% | -5.1% |
| Q4 25 | 1.4% | 0.4% | ||
| Q3 25 | 1.6% | 0.5% | ||
| Q2 25 | 0.7% | 0.9% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 1.8% | 0.2% | ||
| Q3 24 | 0.3% | 0.2% | ||
| Q2 24 | 4.0% | 1.0% | ||
| Q1 24 | 4.6% | 0.2% |
| Q4 25 | — | 2.77× | ||
| Q3 25 | -4.17× | 10.70× | ||
| Q2 25 | — | -12.24× | ||
| Q1 25 | 1.00× | -13.01× | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | — | 4.28× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | -3.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
